{
    "SPADE_UN_13508": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13508",
            "Peptide Name": "EKL1",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEY",
            "Sequence Length": 36,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.34367893]Virus:SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.622±0.089 μmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 μmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.746±0.152 μmol/L),inhibition of cell-cell fusion(IC50=0.220±0.034 μmol/L);inhibited authentic SARS-CoV-2 infection in Vero E6 cells(IC50=1.407±0.189 μmol/L);inhibition of multiple HCoV Pseudovirus:SARS-CoV (IC50=6.716±5.937 μmol/L), MERS-CoV(IC50=4.086±0.345 μmol/L), HCoV-OC43(IC50=10.530±3.778 μmol/L), HCoV-NL63(IC50=3.700±0.222 μmol/L), SARSr-CoV-WIV1(IC50=30.270±4.713 μmol/L), and HCoV-Rs3367 (IC50=88.300±24.600 μmol/L),inhibition of authentic HCoV-OC43 infection in RD cells (IC50=20.290±1.092 μmol/L).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "liposomes",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C201H312N42O65S",
            "Mass": 4388.93,
            "PI": 4.39,
            "Net Charge": -5,
            "Hydrophobicity": -0.65,
            "Half Life": "Mammalian:1.4 hourYeast:3 minE.coli:>10 hour",
            "Comments": "The peptide targets a highly conserved target site in HR1 domains in S protein of HCoVs.",
            "Literature": [
                {
                    "Title": "A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.",
                    "Pubmed ID": "34367893",
                    "Reference": "Acta Pharm Sin B. 2021 Aug 2.",
                    "Author": "Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34367893"
                }
            ],
            "Frequent Amino Acids": "ELK",
            "Absent Amino Acids": "CHOPQRUW",
            "Basic Residues": 5,
            "Acidic Residues": 10,
            "Hydrophobic Residues": 16,
            "Polar Residues": 15,
            "Positive Residues": 5,
            "Negative Residues": 10,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13502",
                    "Similarity": 1.0,
                    "Sequence": "SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL"
                },
                {
                    "SPADE_ID": "SPADE_UN_13506",
                    "Similarity": 1.0,
                    "Sequence": "NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYGSGC"
                },
                {
                    "SPADE_ID": "SPADE_UN_13507",
                    "Similarity": 1.0,
                    "Sequence": "SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKW"
                }
            ]
        }
    }
}